The Relative Risk and Incidence of Immune Checkpoint Inhibitors Related Pneumonitis in Patients With Advanced Cancer: A Meta-Analysis

• Κύριοι συγγραφείς: Ke Ma (Συγγραφέας), Yali Lu (Συγγραφέας), Shanshan Jiang (Συγγραφέας), Jiangong Tang (Συγγραφέας), Xin Li (Συγγραφέας), Yuyang Zhang (Συγγραφέας)
• Μορφή: Βιβλίο
• Έκδοση: Frontiers Media S.A., 2018-12-01T00:00:00Z.
• Θέματα: article
• Διαθέσιμο Online: Connect to this object online.

Background: Recently, immune checkpoint inhibitors (ICIs) have been proved one of the most promising anti-cancer therapy, series clinical trials have confirmed their efficacy. But they are also associated with distinctive set of toxic effects, which are recognized as immune-related adverse events. A...